Maximus (MMS) Stock Price, News & Analysis

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MMS shares.
View MMS analyst ratings or view top-rated stocks.

2 brokers have issued twelve-month price objectives for Maximus' shares. Their MMS share price targets range from $102.00 to $102.00. On average, they expect the company's stock price to reach $102.00 in the next twelve months. This suggests a possible upside of 27.9% from the stock's current price.
View analysts price targets for MMS or view top-rated stocks among Wall Street analysts.

Maximus' stock was trading at $83.86 at the start of the year. Since then, MMS stock has decreased by 4.9% and is now trading at $79.78.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our MMS earnings forecast.

Maximus will be holding an earnings conference call on Thursday, May 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Maximus, Inc. (NYSE:MMS) released its quarterly earnings results on Wednesday, February, 7th. The health services provider reported $1.34 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.06. The health services provider had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a trailing twelve-month return on equity of 15.68% and a net margin of 3.73%. The firm's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.94 EPS.

Maximus announced a quarterly dividend on Friday, April 5th. Investors of record on Wednesday, May 15th will be given a dividend of $0.30 per share on Friday, May 31st. This represents a $1.20 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend is Tuesday, May 14th.
Read our dividend analysis for MMS.

Maximus (NYSE:MMS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.49%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 39.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 20.98% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

ETFs with the largest weight of Maximus (NYSE:MMS) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Nuveen Small Cap Select ETF (NSCS), Fidelity Low Volatility Factor ETF (FDLO), Adaptive Growth Opportunities ETF (AGOX), Vanguard Russell 2000 Growth ETF (VTWG) and iShares Russell 2000 Growth ETF (IWO).

Maximus issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of 5.200-5.500 for the period, compared to the consensus estimate of 4.240. The company issued revenue guidance of $5.1 billion-$5.2 billion, compared to the consensus revenue estimate of $5.1 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus' stock is owned by a number of institutional and retail investors. Top institutional investors include Reinhart Partners LLC. (0.38%), Chatham Capital Group Inc. (0.06%), Rowlandmiller & PARTNERS.ADV (0.05%), Bridge City Capital LLC (0.04%), Fulton Bank N.A. (0.01%) and McLean Asset Management Corp (0.00%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michael J Warren, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Teresa Weipert.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.